It’s always better to prevent a disease than to treat it. Vaccine prevent disease in the people who receive them. If enough people are vaccinated against a disease, then the disease cannot spread into their community. This is known as “Community Immunity.”
How do Vaccines Protect from Diseases?
When our immune system recognizes germs that enter the body as “foreign” invaders, or antigens it works not only to clear your body of that invader, but also creates a large number of memory cells that are specifically tuned to react to it. This protection is called immunity. Vaccines contain little bits of a disease – broken down and harless, and when injected, stimulate the production of antibodies. Through vaccination, we develop immunity without suffering from the actual diseases that vaccines prevent.
The Burden of Influenza
- $24.6 billion in economic costs per year in the U.S. related to influenza and pneumonia
New vaccinations for emerging diseases and for infections that have been prevalent in the past offer hope for a healthier future for all.
What can I do?
RCR is currently seeking healthy volunteers for several investigational vaccine research studies. If you are over the age of 18, you could participate in one of the following investigational vaccine studies:
Rochester Clinical Research is currently seeking volunteers who are 18 years or older, who have not had a flu shot in the last 6 months, for an mRNA multivalent influenza vaccine study. The study could last up to 6 months and includes up to 5 visits to our office. If you qualify, compensation is available for your time and travel.
View Trial Details *Compensation for time and travel may be available to those who qualify.
Featured
Rochester Clinical Research is currently seeking volunteers who are 65 years and older for an Influenza vaccine study. The purpose of this study will be to evaluate the safety and immunogenicity of an mRNA vaccine to prevent influenza. Compensation for time and travel is available for around $630 to those who qualify.
View Trial Details *Compensation for time and travel may be available to those who qualify.
Rochester Clinical Research is currently looking for volunteers between the ages of 18 to 59 years old to participate in an RSV study. This study is for people who are considered high-risk, due to underlying health conditions. The study will last approximately 7-8 months and could include 2-3 office visits. Compensation will be available for the trial-related time.
View Trial Details *Compensation for time and travel may be available to those who qualify.
Featured
Rochester Clinical Research is currently seeking participants who are between the ages of 18-60 years old for an HSV-2 genital herpes vaccine study. This study is approximately 15 months long and includes 10 office visits and 12 telephone calls. To qualify for this study, you must have had a diagnosis of genital herpes for at least 1 year. Compensation for your trial-related time is available.
View Trial Details *Compensation for time and travel may be available to those who qualify.
Rochester Clinical Research is currently seeking participants between the ages of 18 to 49 and 60 to 80 years old for a norovirus vaccine study. The study is approximately 14 months long and includes 11 office visits and 8 telephone calls. Compensation for this study is $125 per office visit and $25 per phone call completed.
View Trial Details *Compensation for time and travel may be available to those who qualify.
Featured
Rochester Clinical Research is currently enrolling children between the ages of 2-17 years old for a pediatric RSV vaccine study. The study is approximately 6 months long and will include 2 visits to our office and 2 phone calls. Compensation of $125 per office visit and $60 per phone visit is available for trial-related time.
View Trial Details *Compensation for time and travel may be available to those who qualify.
Featured
Rochester Clinical Research is seeking volunteers between the ages of 60-85 years old for an investigational RSV and human metapneumovirus vaccine study. The study could last approximately 12 months long and include 7 visits to our office along with 5 telephone calls. During this study, you will be compensated for your participation up to $200 per office visit and $50 per phone call.
View Trial Details *Compensation for time and travel may be available to those who qualify.
Rochester Clinical Research is seeking participants between the ages of 18-70 years old for an adult Lyme Disease vaccine study. The study is approximately 19 months long and will include 12-14 visits to our office during that time. There is a 12.5% chance of a placebo in this study. Compensation for your trial-related time will be provided.
View Trial Details *Compensation for time and travel may be available to those who qualify.
Rochester Clinical Research is currently seeking participants who are 50 years or older for a Pneumococcal vaccine research study. The length of the study is 6 months long and it includes approximately 3-4 visits to the office and 6 telephone calls. To qualify, you can’t have had a previous pneumococcal vaccine. For your participation, you will be compensated for your trial related time.
View Trial Details *Compensation for time and travel may be available to those who qualify.
Rochester Clinical Research is currently seeking volunteers between the ages of 18-50 years old, who have not had a flu shot in the last 6 months, for an mRNA multivalent influenza vaccine study. The study could last up to 7 months and includes up to 6 visits to our office and 2 phone/virtual contacts. If you qualify, compensation is available for your time and travel.
View Trial Details *Compensation for time and travel may be available to those who qualify.
Rochester Clinical Research is looking for participants 12 -17 years old for a Covid-19 booster study. This study is approximately 12 months long and includes 5 visits to our office along with 3 telephone calls. Compensation is available if you qualify to participate.
View Trial Details *Compensation for time and travel may be available to those who qualify.
Rochester Clinical Research is currently seeking healthy volunteers between the ages of 18-55 years old to participate in an mRNA vaccine study to help potentially prevent the Epstein-Barr Virus. The study is 13 months long and includes 11 visits to our office. Compensation is available for your time and travels to participate.
View Trial Details *Compensation for time and travel may be available to those who qualify.
Rochester Clinical Research is currently looking for individuals to join a vaccine study for the varicella-zoster virus. Varicella is a herpesvirus that can cause chickenpox and shingles infections. The purpose of this study is to evaluate the safety and effectiveness of an mRNA vaccine against the virus. RCR is seeking participants between the ages of 50-69 years old who have not previously received a shingles vaccine. This study could last between 8-12 months to 5 years long and includes at least 10-15 office visits. Reimbursement to participate is available for up to $128 per office visit and $5 for every diary entry completed.
View Trial Details *Compensation for time and travel may be available to those who qualify.
Rochester Clinical Research is currently seeking volunteers between the ages of 9-15 years old to participate in a preventative CMV vaccine study. The purpose of this study is to vaccinate children against the virus to prevent them from spreading it to adults, especially women that may be planning on becoming pregnant in the foreseeable future. The study is approximately 18 months long and includes 12 visits in total.
View Trial Details *Compensation for time and travel may be available to those who qualify.
Featured
There is currently no vaccine to prevent or protect against Lyme. RCR is currently conducting a vaccine study to help prevent Lyme disease from infecting adolescents between the ages of 5 to 17. This study will last approximately 24 months with 6 visits to our RCR office and 2 telephone calls.
View Trial Details *Compensation for time and travel may be available to those who qualify.
Rochester Clinical Research is currently seeking born-female volunteers who are 16 or 17 years old to participate in a CMV vaccine study. The purpose of this study is to find a safe and effective vaccine against Cytomegalovirus.
View Trial Details 
